Clinical trial
The Role of MACitentan on the Prevention of Residual Pulmonary vasculaR Occlusion
NCT05946811 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of MACitentan on the Prevention of Residual Pulmonary vasculaR Occlusion
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- May 1, 2024
- Completion date
- June 1, 2028
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.